Under stress conditions such as infection or inflammation the body rapidly needs to generate new blood cells that are adapted to the challenge. Haematopoietic cytokines are known to increase output of specific mature cells by affecting survival, expansion and differentiation of lineage-committed progenitors 1, 2 , but it has been debated whether long-term haematopoietic stem cells (HSCs) are susceptible to direct lineage-specifying effects of cytokines. Although genetic changes in transcription factor balance can sensitize HSCs to cytokine instruction 3 , the initiation of HSC commitment is generally thought to be triggered by stochastic fluctuation in cell-intrinsic regulators such as lineage-specific transcription factors [4] [5] [6] [7] , leaving cytokines to ensure survival and proliferation of the progeny cells 8, 9 . Here we show that macrophage colonystimulating factor (M-CSF, also called CSF1), a myeloid cytokine released during infection and inflammation, can directly induce the myeloid master regulator PU.1 and instruct myeloid cell-fate change in mouse HSCs, independently of selective survival or proliferation. Video imaging and single-cell gene expression analysis revealed that stimulation of highly purified HSCs with M-CSF in culture resulted in activation of the PU.1 promoter and an increased number of PU.1 1 cells with myeloid gene signature and differentiation potential. In vivo, high systemic levels of M-CSF directly stimulated M-CSF-receptor-dependent activation of endogenous PU.1 protein in single HSCs and induced a PU.1-dependent myeloid differentiation preference. Our data demonstrate that lineage-specific cytokines can act directly on HSCs in vitro and in vivo to instruct a change of cell identity. This fundamentally changes the current view of how HSCs respond to environmental challenge and implicates stress-induced cytokines as direct instructors of HSC fate.
Lineage-specific cytokines such as M-CSF can be strongly induced during physiological stress or infection 10, 11 and potently increase the production of mature cells from lineage-committed progenitors 1, 2 . According to the prevailing model, however, they are generally not believed to influence differentiation decisions of HSCs directly 9, 12, 13 . Cell fate choice of HSCs has traditionally been explained by stochastic models 14 . In this view transcriptional noise 15 and random variations in competing lineage-determining transcription factors lead to crossantagonistic switches that initiate lineage choice [4] [5] [6] [7] , whereas cytokines are thought to only act on the resulting progeny cells by stimulating their survival and proliferation 8, 9 . A key example of such a master regulator is the transcription factor PU.1 that induces myelo-monocytic differentiation 16, 17 . It is generally unknown whether external signals could drive the initial activation of such intrinsic master regulators. Because HSCs deficient for the transcription factor MAFB are sensitized to PU.1 activation in response to M-CSF 3 , we have investigated whether high systemic M-CSF levels could induce PU.1 and instruct myelo-monocytic fate in wild-type HSCs without previous modification of transcription factor balance.
We observed that lipopolysaccharide (LPS), a strong mimetic of bacterial infection stimulating high systemic levels of M-CSF 11 (Supplementary Fig. 1a) , induced an upregulation of GFP in long-term HSCs (CD117
) of PU.1-GFP reporter mice 18 ( Supplementary Fig. 1b, c) . Consistent with the expression of the M-CSF receptor (M-CSFR; also called Csf1r) in HSCs ( Supplementary Fig. 2 ) 3, 19 , direct intravenous injection of recombinant M-CSF also induced significantly increased PU.1 activation in HSCs after 16 h (Fig. 1a, b) . The treatment caused no significant change in M-CSFR or Mafb expression ( Supplementary Fig. 3 ), arguing against selection of myeloid primed HSCs with high M-CSFR or low MAFB levels. M-CSF also induced no change in the proportion of CD150 hi HSCs, reported to have myeloid lineage bias 20 , in GFP-positive or GFPnegative HSCs ( Supplementary Fig. 4a-c) and activated PU.1 to a similar extent in CD150
hi HSCs (Fig. 1c) as in total HSCs (Fig. 1a, b) . Finally, cultured CD150
hi HSCs revealed no proliferation or survival advantage in the presence of M-CSF ( Supplementary Fig. 5a ). Together, these data argued against selective amplification or survival of a pre-existing HSC sub-population and indicated that M-CSF could newly induce PU.1 expression in HSCs.
As shown in Fig. 1d , the effect of M-CSF on stem cells was direct and specific, as fluorescence-activated cell sorting (FACS)-purified HSCs Fig. 14) . f, g, Representative FACS profiles (f) and quantification of the ratio (g) of donor GMP and MEP progenitors derived from transplanted PU. 
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showed increased PU.1 expression after 16 h in culture with M-CSF but not with GM-CSF or G-CSF, cytokines that may also be released during infection 21 . The observed changes in gene expression cannot be explained by M-CSF-dependent selection of PU.1-reporter positive (PU.1 1 ) cells, as video microscopy of cultured HSCs showed no proliferation or survival advantage in M-CSF and PU.1 was induced before the onset of cell division (Supplementary Figs 5 and 6 ). Continuous observation of individual GFP-negative sorted HSCs from PU.1-GFP mice by video imaging confirmed that M-CSF could induce PU.1 expression in previously PU.1-negative cells (Fig. 2a-c and Supplementary Videos 1-3) . We recorded the fate of HSCs between 18 h and 42 h of culture, when both the induction of PU.1 in previously negative cells and the division of PU.1 1 cells could theoretically occur. At the end of the 24-h observation period, over twofold more PU.1 1 cells had developed in M-CSF than under control conditions (Fig. 2d) 1 cells was entirely due to M-CSFinduced activation of the PU.1 reporter. These commitment events of PU.1 activation occurred 8 h earlier and at a higher rate over the whole observation period in the presence of M-CSF (Fig. 2e) . Our results indicated that M-CSF could directly increase PU.1 promoter activation in single, previously PU.1-negative HSCs.
To investigate further whether M-CSF-induced PU.1 activation changed the cell identity of individual HSCs we analysed the messenger RNA expression profile of single cells by nanofluidic real-time PCR on Fluidigm dynamic arrays. Consistent with their stem-cell identity, almost all freshly isolated HSCs expressed stem-and progenitor-cellassociated genes and about half expressed either no (Lin 2 ) or multiple lineage-specific genes (mix). The remainder showed mainly megakaryocytic, megakaryocytic-erythroid or myeloid lineage priming ( Fig. 3a and Supplementary Fig. 7 ). Culture for 16 h without M-CSF led to an increased number of cells with a mixed lineage profile at the expense of megakaryocytic and Lin 2 profiles (Fig. 3b and Supplementary Fig. 8 ). By contrast, culture in the presence of M-CSF induced a strong increase of cells with a myeloid gene expression signature (Fig. 3c,  Supplementary Fig. 9 and Supplementary Table 1) . Consistent with the video microscopy results, the increase in myeloid gene expression was associated with a doubling of the number of PU.1 1 cells (Fig. 3d) . Interestingly, this increase was entirely due to PU.1 1 cells with a myeloid signature that did not express genes from any other lineage. By contrast, the number of PU.1 1 cells that also expressed non-myeloid genes remained approximately constant (Fig. 3d) HSCs after in vivo priming with M-CSF (Fig. 3e) . Progenitor analysis in the spleen 2 weeks after transplantation of these populations revealed a higher ratio of granulocyte/macrophage progenitors (GMP) to megakaryocytic/erythroid progenitors (MEP) developing from PU.1 1 HSCs than from PU.1
2 HSCs (Fig. 3f, g ). We observed a similar increase in myeloid differentiation potential for PU.1 1 cells derived from M-CSF-stimulated PU.1 2 HSCs in culture ( Supplementary Fig. 10a-d) . Together, these data showed that M-CSF-induced PU.1 activation led to a myeloid cell fate change in single HSCs.
To investigate further whether M-CSF could also induce a cell fate change of individual HSCs in vivo, we transplanted carboxy fluorescein diacetate, succinimidyl ester (CFSE)-labelled HSCs into the spleen, a site of extra-medullary haematopoiesis with adapted stemcell niches 3, 24 , and analysed the expression of endogenous PU.1 protein by immunofluorescence in single HSCs after 24 h (Fig. 4a) . Whereas 1 cells 24 h after transplantation of HSCs into M-CSF-stimulated hosts in the absence or presence of kinase inhibitors for M-CSFR (GW2580), PI(3)K (LY294002), ERK/MAPK (PD98059) and SRC (SU6656) (n 5 50). g, Ratio of donor GMP to MEP progenitors in the spleens of sub-lethally irradiated recipients 2 weeks after transplantation of in vivo M-CSF-primed or control HSCs. Experimental design is shown in Supplementary Fig. 11 . ***P 5 0.003, calculated by a twotailed non-parametric Mann-Whitney U-test; n 5 8, 9. h, Donor contribution to blood of competitively reconstituted mice 4 weeks and 6 weeks after transplantation of M-CSF-primed or control HSCs, expressed as a ratio of 
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the vast majority of HSCs were PU.1-negative immediately after transplantation, nearly all had activated PU.1 after transfer into spleens of LPS-challenged hosts (Fig. 4b, c) . This effect was principally dependent on M-CSF signalling, as a blocking antibody against the M-CSF receptor 25 strongly inhibited PU.1 activation. Furthermore, direct injection of recombinant M-CSF resulted in a similar strong induction of PU.1 in the transplanted HSCs (Fig. 4b, c) . This effect appeared to be entirely cell autonomous, as M-CSF-receptor-deficient (M-CSFR 2/2 ) 26 HSCs showed no higher activation of PU.1 in M-CSFstimulated compared with control recipients (Fig. 4d, e) . Similarly, small-molecule inhibitors of the M-CSFR or phosphatidylinositol-3-OH kinase (PI(3)K), ERK and SRC kinases, which signal downstream of the receptor 27 , also prevented induction of PU.1 (Fig. 4f) , consistent with the stimulation of transcriptional activators of the PU.1 gene by these pathways (Supplementary Discussion). Furthermore, transplantation of in vivo M-CSF-primed CD45.2 HSCs into sub-lethally irradiated CD45.1 recipients revealed an increased ratio of GMP to MEP progenitors in the spleen after 2 weeks (Fig. 4g and Supplementary Fig. 11a, b) and an increased myeloid to lymphoid cell ratio in peripheral blood after 4 weeks (Supplementary Fig. 11c ). In competitive transplantation assays, M-CSF-primed HSCs also showed a myeloid advantage compared to platelet and lymphoid contribution at 4 weeks in the blood that re-equilibrated after 6 weeks and did not compromise long-term multi-lineage contribution ( Fig. 4h and Supplementary Fig. 12 ). Finally, this myeloid differentiation preference of M-CSF-primed HSCs could be abolished by deletion of PU.1 ( Fig. 4i and Supplementary Fig. 13 ). Together, these results indicated that M-CSF could directly instruct a change in cell identity of single HSCs in vivo that resulted in a reversible, PU.1-dependent myeloid differentiation preference.
Our results show that under haematopoietic stress conditions of infection, high systemic levels of M-CSF can directly instruct myeloid gene expression and differentiation preference of HSCs. This challenges both the current view of cytokine action and how HSCs make differentiation decisions. Whereas cytokines are commonly thought to act on lineage-committed progenitors, we show here that stem cells are direct targets of lineage instruction by cytokines. HSCs have been shown to proliferate in response to signals characteristic of bacterial 28 or viral infections 29 but without changing lineage-specific gene expression or differentiation potential. In line with the prevailing paradigm of selective cytokine action it has been proposed that distinct stem-cell subtypes could have a selective advantage in response to different stimuli 30 . Such a mechanism is difficult to distinguish from instructive mechanisms on a population basis. We have therefore used multiple assays of single-cell analysis in culture and in vivo in a time window before the onset of cell division to distinguish induced changes of lineage specification from selective mechanisms. These data indicate that M-CSF can directly change stem-cell identity by activation of the myeloid master regulator PU.1 on the promoter, message and protein level, independently of selective survival or proliferation. The multilineage priming of gene expression in HSCs has generally been interpreted as an indication that initial cell-fate decisions are driven solely by stochastic fluctuations in the balance of lineage-specific transcription factors [4] [5] [6] 12, 13 . Our data now indicate that cytokines can not only amplify random choices but also directly activate key regulators of lineage specification, such as PU.1, to instruct lineage fate of HSCs to induce an insult-tailored output of progeny. As M-CSF can transiently increase the production of myeloid progeny without compromising stem-cell activity, it may be useful to ameliorate myeloid cytopenias, particularly to protect patients from infection after stem-cell transplantation.
METHODS SUMMARY
Flow cytometry, bone-marrow transplantation and in vivo immunofluorescence of HSCs were performed essentially as described 3 . Single-cell nano-fluidics-based real-time PCR was performed using a BioMark HD system and 96.96 dynamic arrays (Fluidigm) and video microscopy analysis followed proposed standards 23 . Details of procedures and reagents are described in Methods.
Full Methods and any associated references are available in the online version of the paper.
